Dapagliflozin Improves High‐Fat Diet‐Induced Cognitive Impairment in Female Mice
Our results provide a foundation for the clinical application of SGLT2is as an adjuvant to slow down the progression of central degenerative diseases related to metabolic disorders, such as AD.
Authors
- Mingxia Fan (ORCID: https://orcid.org/0000-0001-8454-3405)
- Zhuoni Xiao (ORCID: https://orcid.org/0000-0002-2030-6045)
- Xiaoxing Xiong (ORCID: https://orcid.org/0000-0001-6983-8547)
- Xiaolin Pang (ORCID: https://orcid.org/0000-0001-5087-2964)
Institutions
- Wuhan University (CN)
- Renmin Hospital of Wuhan University (CN)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/brb3.70361
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47
Funders
- Natural Science Foundation of Hubei Province